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In the mammalian forebrain, the majority of excitatory synapses occur on dendritic
spines. Changes in the number of these structures is important for brain development,
plasticity and the refinement of neuronal circuits. The formation of excitatory synapses
involves the coordinated formation of dendritic spines and targeting of multi-protein
complexes to nascent connections. Recent studies have demonstrated that the
estrogen 17β-estradiol (E2) can rapidly increase the number of dendritic spines, an
effect consistent with the ability of E2 to rapidly influence cognitive function. However,
the molecular composition of E2-induced spines and whether these protrusions
form synaptic connections has not been fully elucidated. Moreover, which estrogen
receptor(s) (ER) mediate these spine-morphogenic responses are not clear. Here, we
report that acute E2 treatment results in the recruitment of postsynaptic density protein
95 (PSD-95) to novel dendritic spines. In addition neuroligin 1 (Nlg-1) and the NMDA
receptor subunit GluN1 are recruited to nascent synapses in cortical neurons. The
presence of these synaptic proteins at nascent synapses suggests that the machinery
to allow pre- and post-synapses to form connections are present in E2-induced spines.
We further demonstrate that E2 treatment results in the rapid and transient activation
of extracellular signal-regulated kinase 1/2 (ERK1/2), Akt and the mammalian target of
rapamycin (mTOR) signaling pathways. However, only ERK1/2 and Akt are required for
E2-mediated spinogenesis. Using synthetic receptor modulators, we further
demonstrate that activation of the estrogen receptor beta (ERβ) but not alpha
(ERα) mimics rapid E2-induced spinogenesis and synaptogenesis. Taken together these
findings suggest that in primary cortical neurons, E2 signaling via ERβ, but not through
ERα, is capable of remodeling neuronal circuits by increasing the number of excitatory
synapses.
Keywords: 17β-estradiol, PSD-95, dendritic spines, neuroligin-1, estrogen receptor, ERK1/2, Akt, mTOR
Abbreviations: PSD-95, postsynaptic density protein 95; E2, 17β-estradiol; ERα, estrogen receptor alpha;
ERβ, estrogen receptor beta; PPT, 4, 4′, 4′′; -(4-Propyl-[1H]-pyrazole-1, 3, 5-triyl) trisphenol; WAY-
200070 (070), 7-Bromo-2-(4-hydroxyphenyl)-1, 3-benzoxazol-5-ol; NMDAR, N-methyl-D-aspartate receptor;
ERK, extracellular signal-regulated kinase; PKB, protein kinase B; PTEN, degradation of phosphatase and
tensin homolog; mTOR, mammalian target of rapamycin (mTOR).
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Introduction
The distribution, number, morphology and strength of synapses
along dendrites are crucial determinants of functional neuronal
connectivity within brain circuits. In the mammalian forebrain,
the majority of excitatory synapses occur on specialized
structures known as dendritic spines, which protrude along
the length of the dendritic shaft. Functionally, dendritic
spines house and compartmentalize the postsynaptic density
(PSD), an electron-dense structure containing post-synaptic
neurotransmitter receptors, scaffold proteins, and other signaling
molecules (Sheng and Kim, 2011). The formation of excitatory
synapses requires the coordinated assembly of a large number
of protein complexes into the PSD (McAllister, 2007). Many
of these proteins are tethered to the PSD though interactions
with scaffolding proteins, such as postsynaptic density protein
95 (PSD-95), and play critical roles in synaptic and structural
plasticity, glutamate receptor trafficking, and signal transduction
(Sheng and Kim, 2011). Recent investigations into the molecular
mechanisms of synapse formation have identified several critical
events. The recruitment of PSD-95, when part of a protein
complex with the trans-synaptic adhesion protein neuroligin-1
(Nlg-1) and N-methyl-D-aspartate receptors (NMDARs), is key
for synapse formation (Washbourne et al., 2002; Gerrow et al.,
2006; Barrow et al., 2009). Furthermore, Nlg-1 is required for
the formation and specification of excitatory synapses (Chubykin
et al., 2007; Kwon et al., 2012) while both PSD-95 and Nlg-1 are
also required for the activity-dependent stabilization of dendritic
filopodia into dendritic spines (Chubykin et al., 2007; Gutiérrez
et al., 2009; Kwon et al., 2012). Thus, the presence of these
multi-protein complexes at nascent synapses strongly suggests
their contributions in the formation of functional connections
(McAllister, 2007).
Estrogens, in particular 17β-estradiol (E2), have consistently
been shown to regulate and shape synapse structure and
function, consistent with the remodeling of neuronal circuitry
and the enhancement of cognitive function (Luine and
Frankfurt, 2012; Srivastava et al., 2013; Sellers et al., 2015).
Interestingly, the cognitive enhancing abilities of E2 are not
limited to the classic long-term effects of E2, but can also
occur within a rapid (less than 1 h) time frame (Ervin
et al., 2013; Srivastava et al., 2013). In addition, activation
of the extracellular signal-regulated kinase 1/2 (ERK1/2) and
the phoshoinositide 3-kinase (PI3-Kinase) target Akt (also
known as protein kinase B, (PKB)) have been shown to be
important for the cognitive enhancing abilities of E2 (Fernandez
et al., 2008; Fan et al., 2010). More recently it has also
been suggested that E2-mediated cognitive enhancements may
require local protein synthesis, mediated by the mammalian
target of rapamycin (mTOR) kinase pathway (Fortress et al.,
2013; Sellers et al., 2015). Consistent with the cognitive
enhancing properties, we and others have shown that E2 rapidly
increases spine density on cortical and hippocampal neurons
within 30 min, suggesting the formation of nascent synaptic
connections (Srivastava et al., 2008, 2010; Inagaki et al., 2012).
However, whether E2-induced spines are forming synaptic
connections, and the precise signaling mechanisms that mediate
E2-induced spinogenesis, is currently unclear. Investigations into
the estrogen receptors (ERs) that underlie the rapid modulation
of synapse density have also identified divergent roles for
estrogen receptor alpha (ERα) and beta (ERβ) dependent on
the brain region examined (Mukai et al., 2007; Srivastava et al.,
2010, 2013). Recent studies have shown that ERβ, but not
ERα, can modulate glutamatergic signaling in cortical neurons
(Galvin and Ninan, 2014), but which ER is required for
E2-mediated spinogenesis in cortical neurons is currently not
known.
In this study we have investigated rapid estrogenic-mediated
spinogenesis and synaptogenesis. Our data demonstrates that
in primary cortical neurons E2 induces the recruitment of
the synaptic proteins PSD-95, Nlg-1, and the NMDA receptor
subunit GluN1 to synapses within 30min, indicating that nascent
spines were capabel of forming synaptic connections. We further
found that E2 rapidly activated ERK1/2, Akt and mTOR kinase
pathways, but that only ERK1/2 and Akt pathways were required
for E2-induced spinogenesis. Additionally, acute activation of
ERβ, but not ERα, was sufficient to increase the density of PSD-95
containing spines in cortical neurons. Taken together, these data
suggest that: E2-induced spines are capable of forming synaptic
connections; the formation of these nascent connections occurs
via the action of specific kinase pathways; and ERβ plays a critical
role in mediating the rapid effects of E2 on spinogenesis and
synaptogenesis in cortical neurons.
Methods
Reagents
Antibodies used: GFP chicken polyclonal (ab13972; Abcam);
Phospho-p44/42 MAPK (ERK1/2; Thr202/Tyr204) rabbit
monoclonal (D13.14.4E; #4370), ERK1/2 mouse monoclonal
(L34F12; #4696), phospho-Akt (Ser473) rabbit monoclonal
(D9E; #4060), Akt mouse monoclonal (40D4; #2920), phospho-
mTOR (Ser2448) rabbit monoclonal (D9C2; #5536) and mTOR
mouse monoclonal (L27D4; #4517) antibodies were all from Cell
Signaling Technologies; these antibodies have previously been
used to examine rapid steroid signaling in neurons (Srivastava
et al., 2005; Briz and Baudry, 2014). GluN1 NMDA receptor
subunit mouse monoclonal antibody (556308; BD Biosciences),
PSD-95 mouse monoclonal antibody (clone K28/43; 73-028;
NeuroMab) and neuroligin1 rabbit polyclonal antibody (H-45;
sc-50393; Santa Cruz) have previously been validated and used
to examine synaptic localization of these synaptic proteins in
primary cortical neurons (Srivastava et al., 2008, 2010; Woolfrey
et al., 2009). The ERα (H-184, sc-7207) and ERβ (H-150, sc-8974)
rabbit polyclonal antibodies were from Santa Cruz and have
previously been used to examine the extranuclear localization
of both receptors in neurons (Milner et al., 2005; Dominguez
and Micevych, 2010). 17β-estradiol (E8875) was from Sigma
and estrogen receptor agonists PPT (1426) and WAY-200070
(3366) were from Tocris. The specificity of WAY-200070 for
ERβ has previously been documented: EC50 ERβ: 2.3 nM vs.
ERα: 155 nM (Hughes et al., 2008; Liu et al., 2008). The kinase
inhibitors U0126 (MEK kinase inhibitor) (9903S) and LY294002
(PI3-Kinase inhibitor) (9901S) were from Cell Signaling
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Technologies and rapamycin (mTOR inhibitor) (sc-3504) was
from Santa Cruz.
Neuronal Culture and Transfections
Mixed sex cortical neuronal cultures were prepared from
Sprague-Dawley rat E18 embryos as described previously
(Srivastava et al., 2011). Animals were habituated for 3 days
before experimental procedures, which were carried out
in accordance with the Home Office Animals (Scientific
procedures) Act, United Kingdom, 1986. Cells were plated
onto 18 mm glass coverslips (No 1.5; 0117580, Marienfeld-
Superior GmbH and Co.), coated with poly-D-lysine
(0.2 mg/ml, Sigma), at a density of 3 × 105/well equal to
857/mm2. Neurons were cultured in feeding media: neurobasal
medium (21103049) supplemented with 2% B27 (17504044),
0.5 mM glutamine (25030024) and 1% penicillin:streptomycin
(15070063) (all reagents from Life technologies). Neuron
cultures were maintained in presence of 200 µM D, L-amino-
phosphonovalerate (D, L-APV, ab120004, Abcam) beginning on
DIV (days in vitro) 4 in order to maintain neuronal health for
long-term culturing and to reduce cell death due to excessive
Ca2+ cytotoxicity via over-active NMDA receptors (Srivastava
et al., 2011). We have previously shown that the presence or
absence of APV in the culture media does not affect E2’s ability
to increase spine linear density (Srivastava et al., 2008). Half
media changes were performed twice weekly until desired age
(DIV 23–25). The primary cortical neurons were transfected
with eGFP at DIV 23 for 2 days, using Lipofectamine 2000
(11668027, Life Technologies) (Srivastava et al., 2011). Briefly,
4 µg of plasmid DNA was mixed with Lipofectamine 2000 and
incubated for 4–12 h, before being replaced with fresh feeding
media. Transfections were allowed to proceed for 2 days, which
results in approximately 10% transfection efficacy (Xie et al.,
2007; Srivastava et al., 2011). Constructs for ERα and ERβ were
previously generated and validated: GFP-tagged ERα (Stenoien
et al., 2000); V5-tagged ERβ (Wittmann et al., 2007); both
constructs were purchased from Addgene.
Pharmacological Treatments of Neuron Culture
All pharmacological treatments were performed in artificial
cerebral spinal fluid (aCSF): (in mM) 125 NaCl, 2.5 KCL,
26.2 NaHCO3, 1 NaH2PO4, 11 glucose, 5 Hepes, 2.5 CaCl2,
1.25 MgCl2, and 0.2 APV). For kinase inhibitor experiments,
neurons were pre-treated for 30 min before application of E2
directly over neurons. All compounds were dissolved in either
100% ethanol or DMSO at a concentration of 10 or 1 mM,
and serially diluted to a 10X working concentration in aCSF,
and applied directly to neuronal cultures. Final concentration
of solvent was <0.01%: vehicle control was made up of solvent
lacking compound, diluted as test compounds. Treatments were
allowed to proceed for indicated time before being lysed for
Western blotting or fixed for immunocytochemistry (ICC).
Immunocytohistochemistry (ICC)
Neurons were washed in PBS and then fixed in either 4%
formaldehyde/4% sucrose PBS for 10 min at room temperature
followed by incubation in methanol pre-chilled to −20◦C
for 10 min at 4◦C, or in methanol (−20◦C) only for 20
min at 4◦C. Fixed neurons were then permeabilized and
blocked simultaneously (2% Normal Goat Serum, 5425S,
Sigma and 0.2% triton x-100) before incubation in primary
antibodies overnight and subsequent incubation with secondary
antibodies the following day (Srivastava et al., 2011). In the
green/purple color scheme, co-localization is indicated by white
overlap.
Quantitative Analysis of Spine Morphologies and
Immunofluorescence
Confocal images of double-stained neurons were acquired with
a Leica SP-5 confocal microscope using a 63x oil-immersion
objective (Leica, N.A. 1.4) as a z-series. Two-dimensional
maximum projection reconstructions of images were generated
and morphometric analysis (spine number, area and breadth)
was done using MetaMorph software (Universal Imaging
Corporation) (Srivastava et al., 2011). Morphometric analysis
was performed on spines from at least two dendrites
(secondary or tertiary branches), totaling 100 µm, from
each neuron. Linear density and total gray value of each
synaptic protein cluster was measured automatically using
MetaMorph (Srivastava et al., 2011). Cultures directly
compared were stained simultaneously and imaged with
the same acquisition parameters. For each condition, 9–12
neurons from at least 3 separate experiments were used.
Experiments were carried out blind to condition and on sister
cultures.
Statistical Analysis
All statistical analysis was performed in GraphPad. Differences
in quantitative immunofluorescence, dendritic spine number
and morphology were identified by Student’s unpaired t-tests.
For comparisons between multiple conditions the main effects
and simple effects were probed by 1- or 2-way ANOVAs with
Tukey correction for multiple comparisons. Error bars represent
standard errors of the mean.
Results
E2 Increases the Number of PSD-95 Containing
Dendritic Spines
The scaffolding protein PSD-95 is one of the earliest detectable
proteins at the PSD in nascent synaptic connections (Gerrow
et al., 2006; McAllister, 2007). It is a critical component of
dendritic spines and key for synapse maturation and LTP
through its ability to localize several critical synaptic proteins,
including neurotransmitter receptors (Sheng and Kim, 2011).
As our previous work indicates that E2 can induce the rapid
formation of novel dendritic spines (Srivastava et al., 2008),
we reasoned that E2-induced spines may also contain PSD-95.
To test this we treated DIV 25 primary cortical neurons with
10 nM E2 or vehicle for 30 min: this resulted in an increase
in the number of overall PSD-95 puncta (PSD-95 puncta per
10 µm ctl, 5.35 ± 0.39; E2, 10.24 ± 0.54; Figures 1A,B). To
determine whether this increase in PSD-95 puncta correlated
with an increase in spine linear density, we treated eGFP
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FIGURE 1 | E2 rapidly recruits PSD-95 to nascent spines. (A) Primary
cortical neurons (DIV 25) processed for PSD-95 immunostaining following
treatment with 10 nM E2 or vehicle (30 min). Yellow dashed box denotes
section of dendrite magnified in insets. (B) Quantification of puncta linear
density in neurons from (A) reveals an increase in overall PSD-95 expression
after E2 treatment (∗∗∗p < 0.001; n = 10–12 cells per condition). (C,D)
Representative confocal image of dendritic spines on secondary dendrites
from eGFP expressing primary cortical neurons (DIV 25) co-stained for
PSD-95. Treatment with E2 for 30 min increased the number of dendritic
spines containing PSD-95. (∗∗p < 0.01; n = 13 cells per condition). Scale bar
= 50 µm (A); 5 µm (A, inset) and (C).
expressing neurons with E2 for 30 min and double labeled for
GFP and PSD-95 (Figure 1C). Consistent with our previous
data (Srivastava et al., 2008), E2 significantly increased spine
linear density after 30 min (spine density per 10 µm: ctl,
5.4 ± 0.41; E2, 9.4 ± 0.9; Figures 1C,D). A similar increase
in PSD-95 containing spines was also seen after E2 treatment:
while the linear density of total spines increased by ∼57%, an
increase of ∼61% was seen in the number of PSD-95 containing
spines following treatment indicating that E2-induced spines
also contained this synaptic protein (Total spines vs. Spines +
PSD-95 (per 10 µm): ctl, 5.4 ± 0.41 vs. 4.8 ± 0.34; E2, 9.4
± 0.9 vs. 7.5 ± 1.04; Figure 1D). Under control conditions
approximately 84% of spines were positive for PSD-95, while
following E2 treatment ∼81% of spines were found to contain
PSD-95. Collectively, these data demonstrate that, concurrent
with the rapid formation of nascent dendritic spines, E2
treatment results in the recruitment of PSD-95 to newly formed
spines.
Regulation of Post-Synaptic Synaptic Proteins
by E2
Since E2 rapidly increases the number of PSD-95 containing
spines, we reasoned that a similar effect may be seen in
synaptic proteins known to interact with this scaffold protein.
Nlg-1 belongs to the neuroligin/neurexin family of adhesion
proteins and plays an important role in connecting the pre-
and post-synaptic membranes (Gerrow et al., 2006; Barrow
et al., 2009). Accumulation of pre-formed complexes of Nlg-
1 and PSD-95 are thought to be required for the formation of
nascent functional connections (Gerrow et al., 2006; Chubykin
et al., 2007). To see whether treatment with E2 could
also increase the density of Nlg-1/PSD-95 complexes, E2
treated cells were co-stained for Nlg-1 and PSD-95. Under
control conditions, >85% of Nlg-1 puncta co-localized with
PSD-95, indicating the presence of Nlg-1/PSD-95 complexes.
Consistent with an increase in PSD-95 density, following
treatment with E2, an increase in the overall number of
Nlg-1 puncta was observed (Figures 2A,B). Importantly, the
majority of Nlg-1 puncta (∼85%) were still co-localized with
PSD-95 after E2 treatment indicating that E2 had increased
the number of Nlg-1/PSD-95 synaptic complexes (Total Nlg-
1 vs. co-localized Nlg-1/PSD-95 puncta (per 10 µm): ctl,
7.3 ± 0.58 vs. 6.5 ± 0.64; E2, 13.7 ± 1.7 vs. 12.2 ± 1.07;
Figures 2A,B).
One of the most critical events in synaptogenesis is
the recruitment of NMDA receptors to nascent synapses
(Washbourne et al., 2002; Barrow et al., 2009). While we have
previously shown that E2 can rapidly increase the number
of GluN1 NMDA receptor subunits (Srivastava et al., 2008),
it was not clear whether this reflected a targeting of the
receptor subunit to synaptic or extra-synaptic locations. Thus,
to investigate whether E2 treatment resulted in the targeting
of GluN1 to synaptic or extra-synaptic locations, treated
neurons were co-stained for GluN1 and the pre-synaptic marker
synaptotagmin, and assessed for the number of co-localized
puncta. Consistent with our previous data, challenge with E2
increases the total number of GluN1 puncta (Figures 2C,D).
Under control condition, >75% of GluN1 puncta were found
to co-localize with synaptotagmin, indicating a predominance
of synaptic GluN1-containing NMDA receptors. Critically, after
30 min of E2 treatment, concomitant with an increase in GluN1
puncta, we found that the majority of these puncta (>73%)
remained positive for co-localization with synaptotagmin
(Total GluN1 vs. co-localized GluN1/synaptotagmin puntca
(per 10 µm): ctl, 8.5 ± 1.65 vs. 6.8 ± 1.26; E2, 15.7 ± 2.34
vs. 11.6 ± 1.55; Figures 2C,D), strongly suggesting that
E2-mediated increase in GluN1 puncta were being targeted
to synapses. Taken together, these data demonstrate that
E2-induced spinogenesis is accompanied by the targeting of
key proteins required for synaptogenesis to nascent spines.
Thus, E2-induced spines display the hallmarks of being able
to form synaptic connections with appropriate pre-synaptic
partners.
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FIGURE 2 | E2 rapidly increases presence of proteins involved in
synaptogenesis at synapses. (A) Representative confocal images of
primary cortical neurons (DIV 25) fixed following treatment with E2 or vehicle
(30 min). Neurons were immunostaining for Nlg-1 and PSD-95. Insets are of
magnified regions denoted by yellow dashed boxes in low magnification
images (top). (B) Quantification of (A). Nlg-1 puncta density increases
following E2 treatment; a concurrent increase in Nlg-1/PSD-95 co-localized
puncta is also observed (∗∗p < 0.01, n = 9–10 cells). (C) Confocal images of
DIV 25 primary cortical neurons treated with or without E2 for 30 min and
co-stained for NMDA receptor subunit GluN1 and pre-synaptic protein
synaptotagmin. Yellow dashed boxes in low magnification images (top)
indicate region of dendrite magnified in insets. (D) Quantification of (C). After
30 min of treatment with E2, overall GluN1 puncta density increases;
measurements of GluN1/synaptotagmin co-localized puncta also reveal an
increase in density (∗p < 0.05; n = 10 cells per condition). In all images,
overlap is indicated by white. Scale bar = 5 µm.
E2-Induced Spinogenesis Requires Activation of
Distinct Downstream Kinase Pathways
The ability of E2 to induce spinogenesis has been widely reported
(Luine and Frankfurt, 2012; Srivastava et al., 2013; Sellers
et al., 2015); however, the underlying molecular mechanisms
have yet to be fully unraveled. Recent investigations have
shown that in the hippocampus, E2 administration results
in the rapid and transient activation of ERK1/2, Akt, and
degradation of phosphatase and tensin homolog (PTEN),
events which preceded the activation of mammalian target of
rapamycin (mTOR) and induction of local protein synthesis
(Fernandez et al., 2008; Fan et al., 2010; Fortress et al., 2013;
Briz and Baudry, 2014). Phosphorylation (activation) of these
kinases has previously been implicated in multiple neuronal
processes, including spinogenesis (Sweatt, 2004; Jaworski and
Sheng, 2006). In addition, activation of these pathways are
also critical for E2’s ability to enhance performance on object
recognition and object place memory tasks (Fernandez et al.,
2008; Fan et al., 2010; Fortress et al., 2013). However, much
less is known about which kinase pathways are activated in
response to acute E2 treatment in primary cortical neurons
and moreover, whether activation of these pathways is required
for E2-induced spinogenesis. Therefore, in order to ascertain
which kinase pathways were being activated in response to
acute E2 treatment, we examined the temporal course of
kinase activation by Western Blotting. As previously described
(Srivastava et al., 2008) application of E2 resulted in a rapid
increase in ERK1/2 phosphorylation (Figure 3A). ERK1/2
activation was maximal after 10 min and decreased over time, yet
remained elevated compared to baseline at 30 min (Figure 3B).
E2 also induced a similar temporal profile of activation of
Akt (Figure 3A); maximal activation of Akt was observed
after 10 min and decreased with time but also remained
elevated compared to baseline after 30 min (Figure 3B).
In contrast, when we examined the phosphorylation of mTOR,
we found a delayed andmodest activation (Figure 3A); activation
of mTOR was not seen until 15 min, peaking at 20 min, and
persisted until 30 min (Figure 3B).
We next sought to determine whether activation of these
kinase pathways were required for E2-induced spinogenesis.
DIV 25 eGFP expressing cortical neurons were pretreated for
30 min with specific kinase inhibitors before challenge with E2
or vehicle for a further 30 min. We used the following kinase
pathways inhibitors: the MEK/ERK1/2 pathway inhibitor U0126;
LY294002 an inhibitor of the PI3-K/Akt pathway; and the mTOR
inhibitor rapamycin. Treatment with the inhibitors alone did not
affect spine numbers (data not shown). However, inhibition of
the MEK/ERK1/2 and PI3-K/Akt pathways blocked E2-induced
spine formation, but inhibition of mTOR had no effect on
E2-mediated spinogenesis (spine density per 10 µm: ctrl, 5.5 ±
0.28; E2, 8.3 ± 0.42; E2 + U0126, 5.6 ± 0.54; E2 + LY294002,
5.3 ± 0.31; E2 + rapamycin, 8.8 ± 0.57, Figures 3C,D).
Taken together these data demonstrate that E2 is capable
of rapidly activating multiple kinase pathways with different
temporal dynamics in primary cortical neurons. Moreover, that
E2-mediated spinogenesis is dependent on activation of the
MEK/ERK1/2 and PI3-K/Akt, but not mTOR, pathways.
Extranuclear Localization of ERs in Cortical
Neurons
The rapid effects of E2 are thought to be mediated by
membrane bound/associated ERs (Luine and Frankfurt, 2012;
Sellers et al., 2015). Several studies have demonstrated that the
classical ERs, ERα and ERβ, have an extranuclear distribution
in cortical and hippocampal neurons, with a subset of receptors
localizing to synapses (Waters et al., 2011; Almey et al., 2014).
In order to determine whether ERα and ERβ had an extranuclear
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FIGURE 3 | Activation and requirement of specific kinase pathways
during E2-mediated spinogenesis. (A) Western Blot analysis of ERK1/2,
Akt, and mTOR pathways in cell lysates of neurons treated with E2 for
increasing amounts of time. Membranes were incubated with
phospho-specific antibodies followed by incubation with antibodies against
total protein. (B) Quantification of the temporal activation of kinase pathways
following E2 treatment; all time points were compared to 0 min (untreated)
(∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; n = 4 independent experiments).
(C) Representative confocal images of dendritic spines on secondary
dendrites from DIV 25 eGFP expressing primary cortical neurons. Neurons
were pretreated (30 min) with vehicle (ctrl) or MEK/ERK1/2 inhibitor U0126,
PI3-K/Akt inhibitor LY294002, or mTOR inhibitor rapamycin followed by
treatment with vehicle or E2 for an additional 30 min. (D) Quantification of
linear spine density from cells in (C). Pretreatment with U0126 or LY294002
but not rapamycin blocked E2-mediated spinogenesis (∗p < 0.05;
∗∗∗p < 0.001; n = 12–16 cells per condition). Scale bar = 5 µm.
distribution and moreover, localized to synapses in our primary
cortical cultures, we immunostained DIV 25 cortical neurons for
either ERα or ERβ and PSD-95. As previously described (Almey
et al., 2014), both receptors displayed an extranuclear localization
in primary cortical neurons (Figures 4A,B). The specificity of
staining was determined by no primary antibody controls (data
not shown). Confocal imaging of endogenous ERα revealed that
the receptor was localized in the nucleus (white arrow head)
and along dendrites (Figure 4A). When distal dendrites were
examined, ERα was found to be present in punctate structures
along dendrites (Figure 4B; open red arrow heads) with a
subset of ERα puncta co-localizing with PSD-95 (Figure 4B;
yellow arrows). Similarly, endogenous ERβ was present in the
FIGURE 4 | Extranuclear localization of classic estrogen receptors
(ERs) in primary cortical neurons. (A) Representative confocal images of
primary cortical neurons (DIV 23) co-stained for endogenous ERα and
PSD-95. Low magnification images demonstrates nuclear staining for ERα
(white arrow heads) in addition to presence along dendrites. Yellow dashed
boxes indicate magnified dendritic regions shown in (B). (B) High
magnification images reveal that a subset of ERα puncta co-localizes with
PSD-95 (yellow arrows); the remaining puncta are likely present in dendrites
(open red arrow heads). (C) Co-staining of endogenous ERβ and PSD-95
reveals the presence of the receptor in the nucleus (white arrow head) and
along dendrites in DIV 23 primary cortical neurons. (D) Examination of distal
dendrites as denoted by yellow dashed box in (C) reveals that ERβ is present
at both extra-synaptic synaptic regions, as demonstrated by co-localization
(yellow arrows) or lack thereof (open red arrow heads) with PSD-95. (E,F)
Representative confocal images of DIV 25 primary cortical neurons ectopically
co-expressing GFP-ERα or V5-ERβ with mCherry (to outline neuronal
morphology). Yellow dashed boxes denote regions of dendrites magnified in
insets. Ectopic ERs localize along dendrites (open red arrow heads) and to
dendritic spines (yellow arrows). Scale bar = 50 µm (A,C,E,F); 5 µm (B,D,E
inset and F inset).
nucleus (white arrow heads) and in punctate structures along the
dendrite (Figure 4C). ERβ puncta were also observed along distal
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dendrites (Figure 4D; red open arrow heads) where a subset of
puncta co-localized with PSD-95 (Figure 4D; yellow arrows).
However, puncta for both receptors that did not co-localize
with PSD-95 were also observed, suggesting that these receptors
are additionally present at extrasynaptic regions, potentially
along dendrites (Figures 4B,C, open red arrow heads). This
subcellular distribution is consistent with the receptors being
able to engage with the machinery required for the formation of
dendritic spines.
Recently the specificity of estrogen receptor antibodies have
been called into question (Snyder et al., 2010). Therefore, in
order to confirm the post-synaptic localization of ERα and
ERβ, we ectopically expressed GFP-tagged ERα or V5-tagged
ERβ constructs in DIV 25 cortical neurons (Figures 4E,F).
Co-expression of GFP-ERα with mCherry, as a morphological
marker, demonstrated that ectopic ERα localized along dendrites
(open red arrow heads) and in dendritic spines (Figure 4E; yellow
arrows). In a similar manner, co-expression of V5-ERβ with
mCherry also revealed immunoreactive staining for the receptor
along dendrites (open red arrow heads) and within a subset of
dendritic spines also being positive for ERβ (Figure 4F; yellow
arrows). Collectively, these data suggest that the classic ERs, ERα
and ERβ, have an extranuclear distribution in cortical neurons
and furthermore, are present at a subset of synapses and dendritic
spines, locating them at an ideal site in which to mediate rapid
estrogenic-mediated spinogenesis and synaptogenesis.
Regulation of Rapid Spinogenesis and
Synaptogenesis by Distinct ERs
Previous studies have indicated divergent roles of ERα and
ERβ in E2-mediated spinogenesis. In hippocampal neurons,
activation of ERα, but not ERβ has been shown to result in an
increase in spine linear density (Mukai et al., 2007). In contrast,
activation of ERβ has been shown to increase spine density
in cortical neurons (Srivastava et al., 2010). However, a direct
comparison of the contribution of ERα and ERβ to E2-mediated
spinogenesis in cortical neurons has not been performed. As our
data suggests that both ERα and ERβ are ideally localized to
regulate spine-morphogenic actions, we investigated the effects
of acutely activating ERα or ERβ using specific agonists, on
spine linear density. To evaluate whether signaling through
either ER could induce spinogenesis within a rapid time-frame,
eGFP-expressing cortical neurons were treated with 100 nM
PPT, 10 nM WAY-200070 (070), agonists for ERα or ERβ
respectively, or vehicle for 30 min. Treatment with PPT did not
significantly alter the number of spines compared to controls
within 30 min (Figures 5A,B). Conversely, treatment with 070
for 30 min significantly increased spine linear density, accordant
with previous findings (spine density per 10 µm: Ctl, 5.8 ± 0.49;
PPT, 5.6 ± 0.31; 070, 10.1 ± 0.68; Figures 5A,B) (Srivastava
et al., 2010). A detailed analysis of dendritic spine morphology
revealed that treatment with 070 resulted in spines with a smaller
area (spine area (µm2): Ctl, 0.77 ± 0.035; PPT, 0.7 ± 0.035;
070, 0.62 ± 0.032; Figure 5C). This reduction was reflected
by a reduction in the average breadth of spines (spine breadth
(µm): Ctl, 0.87 ± 0.024; PPT, 0.81 ± 0.026; 070, 0.70 ± 0.027;
Figure 5D); treatment with PPT had no effect on either spine area
or spine breadth. Taken together, these data demonstrate that in
primary cortical neurons activation of ERβ, but not ERα, results
in an increase in thin-like dendritic spines.
As E2 treatment induced an increase in the number of spines
containing PSD-95 (Figure 1) we next asked whether activation
of specific ERs could also recruit this scaffold proteins to
nascent synapses. Examination of total PSD-95 puncta revealed
that treatment with 070, but not PPT, increased the linear
density of PSD-95 puncta within 30 min (PSD-95 puntca
(per 10 µm): Ctl, 6.7 ± 0.49; 30 min, PPT, 6.3 ± 0.0.51;
070, 11.7 ± 1.13; Figures 5E,F). We next examined whether
ERβ-induced spines also contained PSD-95 by quantifying the
number of PSD-95 positive spines. As seen before, under control
conditions, the majority of (>75%) spines were positive for
PSD-95 (Figures 5G,H). Treatment with PPT did not alter
the density of spines containing PSD-95 compared to control.
However, treatment with 070 resulted in an increase in the
number of spines containing PSD-95 paralleling the effects of E2
on PSD-95 containing spines (Total spines vs. Spines + PSD-95
(per 10 µm): Ctl, 5.4 ± 0.39 vs. 4.2 ± 0.32; PPT, 5.5 ± 0.28
vs. 4.7 ± 0.31; 070, 10.2 ± 0.59 vs. 7.9 ± 0.22; Figures 5G,H).
Collectively, these data suggest that ERβ, but not ERα, is required
for rapid estrogenic-mediated spinogenesis and synaptogenesis.
Discussion
Recent studies have begun to uncover the molecular mechanisms
underlying the rapid formation of dendritic spines by estrogens
(Luine and Frankfurt, 2012; Srivastava et al., 2013; Sellers
et al., 2015). However, it is unclear whether E2-induced spines
on cortical neurons form synaptic connections, and which
ER(s) are responsible for mediating these morphogenic effects.
Here we show that, concurrent with the rapid induction
of spinogenesis in cortical neurons by E2, there is also a
recruitment of synaptic proteins, which are required for the
formation excitatory synapses, to nascent dendritic spines.
Specifically we find an increase in the density of PSD-95
positive spines concomitantly with a recruitment of Nlg-1 and
GluN1 to synapses following acute E2 treatment. Furthermore,
we find that while E2 rapidly phosphorylates ERK1/2, Akt
and mTOR, only ERK1/2 and Akt pathways are required
for E2-mediated spinogenesis. In addition, by using synthetic
ER agonists we find that activation of ERβ alone is capable
of inducing rapid spinogenesis and recruitment of PSD-95
to newly formed spines. Collectivity these data suggest that
E2, signaling through ERβ via ERK1/2 and Akt downstream
pathways, increases the number of dendritic spines that contain
the molecular machinery required for synaptogenesis. This
modulation of synaptic connectivity may contribute to rapid
estrogenic remodeling of neuronal circuits and modulation of
cognitive function.
While E2 has repeatedly been shown to rapidly increase the
number of dendritic spines in both cortical and hippocampal
neurons (Mukai et al., 2007; Srivastava et al., 2008), these
studies did not demonstrate whether these nascent protrusions
contained the molecular machinery required for forming
synaptic connections. It is widely accepted that PSD-95 is
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FIGURE 5 | Acute activation of ERβ but not ERα induces formation
of PSD-95 containing dendritic spines. (A) Representative images of
dendritic spines on secondary dendrites of eGFP expressing primary
cortical neurons (DIV 25) following treatment with PPT (100 nM),
WAY-200070 (070; 10 nM) or vehicle (ctl) for 30 min. (B) Quantification of
(A). Treatment with 070, but not PPT increased spine linear density
(∗∗p < 0.01; n = 11–15 cells per condition). (C,D) Detailed analysis of
dendritic spine morphology in response to synthetic ER agonist treatment;
070 leads to decrease in overall spine area and breadth; PPT treatment
has no effect on spine morphology (spine area ∗∗p < 0.01; spine breadth
∗p < 0.05; n = 11–15 cells per condition). (E,F) Confocal images of
primary cortical neurons (DIV 25) immunostained for PSD-95; puncta linear
density increased with treatment 070, but not PPT (∗∗∗p < 0.001; n = 12
cells per condition). (G,H) Representative images of dendritic spines on
eGFP expressing primary cortical neurons (DIV 25), co-stained for
PSD-95, and quantified for number of PSD-95 containing dendritic spines
following application of ER agonists. Activation of ERβ (070) but not ERα
(PPT) for 30 min resulted in an elevation of dendritic spines, and PSD-95
containing spine linear density (∗∗∗p < 0.001 n = 15 cells per condition).
Scale bar = 50 µm (E); 5 µm (A,E inset, and G).
centrally involved in multiple aspects of synaptic function.
PSD-95 has been shown to be necessary for synapse
formation (Gerrow et al., 2006) owing to its ability to bind,
tether, or stabilize various membrane proteins and signaling
molecules in the PSD (McAllister, 2007; Sheng and Kim, 2011).
Our data demonstrates that following acute E2 treatment there
is an increase in the number of PSD-95 containing dendritic
spines, suggesting that E2-induced spines contain the molecular
framework for the presence of a PSD. Furthermore it provides
the necessary scaffold for the recruitment or stabilization of
proteins that are also involved in synaptogenesis at nascent
synapses. Consistent with this, we observed an increase in
the number of Nlg-1/PSD-95 puncta following E2 treatment.
At synapses Nlg-1 anchors both sides of the synapse together by
forming trans-synaptic connections with pre-synaptic neurexins
(Chubykin et al., 2007; Barrow et al., 2009). Thus, the observed
increase in Nlg-1 puncta at synapses, as determined by
overlapping localization with PSD-95 following treatment,
suggests that E2-induced spines can form physical connections
with pre-synaptic termini.
Recent studies have suggested that Nlg-1 is required for
the formation and stabilization of nascent connections through
the recruitment of PSD-95 and NMDA receptors (Chubykin
et al., 2007; Barrow et al., 2009; Gutiérrez et al., 2009; Kwon
et al., 2012). Previously we have shown that E2 rapidly increases
the density of the NMDA receptor subunit GluN1 (Srivastava
et al., 2008). In the present study we demonstrate that GluN1
is indeed recruited specifically to synapses, consistent with
increased synaptic Nlg-1. The presence of GluN1 at synapses is
also in agreement with the formation of synaptic connections,
and based on previous studies, it is likely that GluN1 is recruited
to nascent synapses by PSD-95/Nlg-1 complexes (Barrow
et al., 2009; Gutiérrez et al., 2009). An increase of synaptic
GluN1-containing NMDA receptors suggests that it is well
positioned to respond to subsequent activity-dependent stimuli
(Xie et al., 2007). Furthermore, the importance of increased
localization of GluN1 to synaptic as opposed to extrasynaptic
regions, is demonstrated by the role extrasynaptic NMDA
receptors play in mediating excitotoxicity signals (Paoletti et al.,
2013).
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 April 2015 | Volume 9 | Article 137
Sellers et al. Mechanisms underlying estrogen synapse formation
There is a growing appreciation of the complex manner
by which estrogens may influence multiple aspects of brain
function. E2 has been shown to rapidly activate the ERK1/2,
Akt and mTOR pathways (Briz and Baudry, 2014) highlighting
the fact that estrogens can rapidly modulate multiple functions
via multiple molecular mechanisms in the CNS (McEwen and
Alves, 1999). Interestingly, recent studies have shown that the
rapid activation of both ERK1/2 and Akt pathways are required
for E2 enhancement of performance in object recognition tasks
(Fernandez et al., 2008; Fan et al., 2010). Similarly E2 has
been suggested to enhance performance in object recognition
tasks through local protein synthesis pathways, mediated by the
activation of an mTOR pathway (Fortress et al., 2013). Data from
the present study demonstrates that E2-mediated spinogenesis
in primary cortical neurons requires activation of the ERK1/2
and Akt, but not mTOR pathways. This suggests that the initial
formation of nascent spines does not require protein synthesis;
it is likely that the ERK1/2 and Akt pathways regulate local
signaling. These results complement our previous data, which
demonstrates that E2 rapidly increases spine density even in
the presence of cycloheximide; a protein synthesis inhibitor
(Srivastava et al., 2008). However, it is yet to be determined
whether the induction of a local protein synthesis mechanism, as
mediated by an mTOR pathway, is required for the stabilization
of a nascent synaptic connection and thus consolidation of
memory (Srivastava et al., 2013; Sellers et al., 2015). The results
in this study further add to well documented findings that
suggest signaling via specific ERs have substantial effects on
cognitive processes (Luine and Frankfurt, 2012; Ervin et al.,
2013; Srivastava et al., 2013), and can specifically modulate spine
number via distinct receptors depending on brain regions (Mukai
et al., 2007; Srivastava et al., 2010).
Previous studies have demonstrated that E2 increases spine
density on both cortical neurons of female rats within 30 min
(Inagaki et al., 2012) and CA1 neurons of male rats within a
similar time frame (Mukai et al., 2007; Inagaki et al., 2012).
Our data correlates with these in vivo and ex vivo observations.
Moreover, the reported increase in spine density on cortical
neurons was seen concurrently with enhanced performance in
a number of behavioral tasks (Inagaki et al., 2012), whilst the
increase in spine density in CA1 neurons was seen in addition
to enhanced synaptic plasticity (Mukai et al., 2007). These
observations, thus provide a link between E2-driven changes
in synapse number with both synaptic function and cognition.
Another important consideration is the physiological relevance
of the concentration of E2 used in our study. Levels of plasma
E2 have been reported to be in the lower picomolar range
(Ishii et al., 2007; Hojo et al., 2009; Konkle and McCarthy, 2011),
a concentration that some have argued is not sufficient to elicit
rapid estrogenic signaling (Balthazart and Ball, 2006; Srivastava
et al., 2013). However, several studies have now measured higher
pico- to nanomolar concentrations of E2 within specific brain
regions, including the cortex (Ishii et al., 2007; Hojo et al., 2009;
Konkle and McCarthy, 2011). Indeed, E2 has been previously
demonstrated to be rapidly synthesized through the conversion
of androgens into estrogens by the enzyme aromatase in brain
tissue within 30 min, and may even reach concentrations of
10 nM (Ishii et al., 2007). This high concentration of E2 is
sufficient to trigger a rapid cellular response. High pico and
nanomolar E2 concentrations have been reported in both male
and female brain tissue (Ishii et al., 2007; Hojo et al., 2009;
Konkle and McCarthy, 2011) suggesting that E2 may elicit rapid
responses in both sexes. It is worth acknowledging that in the
current study we have used mixed sex primary neurons, and
thus it is not possible to determine whether the reported effects
are sex specific. Nevertheless, E2 has been reported to rapidly
modulate spine density in both male and females (Mukai et al.,
2007; Inagaki et al., 2012), although this may occur in a sexually
dimorphic manner (Brandt et al., 2013).
In addition to demonstrating the rapid effects of E2 on
spinogenesis and synaptogenesis, we have also established that
ERβ is present at synapses in primary cortical neurons and
is required for the rapid induction of spinogenesis. Although
we find that ERα is also present at synapses, activation of this
receptor did not alter spine density. Whether ERα is required
for the subsequent stabilization of newly formed spines, or the
generation of nascent connections at a different time point in
primary cortical neurons, has yet to be determined. We are also
unable able to ascertain in this study whether ERα acts in a sex
specific manner. Nevertheless we have further demonstrated that
the acute activation of ERβ also results in the recruitment of
PSD-95 to nascent spines, indicating that ERβ-induced spines
are capable of forming synaptic connections. Interestingly these
data correspond with recent evidence that demonstrate signaling
through ERβ, and not ERα, can rapidly influence glutamatergic
signaling and synaptic transmission (Liu et al., 2008; Kramár
et al., 2009; Galvin and Ninan, 2014). These data suggest that
ERβ has a predominate role in regulating both structural and
functional plasticity in cortical neurons. However, recent reports
indicate that GPER1 (formally known as GPR30), an estrogen
responsive G-protein coupled receptor, is present in cortical
neurons and has morphogenic properties (Srivastava and Evans,
2013; Almey et al., 2014). Therefore future studies are required
to determine the contribution of this receptor to the regulation
of synapse formation in cortical neurons to fully understand the
distinct role of each ER in this process.
Data from this study strengthens suggestions that in addition
to rapidly regulating synaptic transmission, estrogens also
regulate the number of physical connections between neurons.
There is an increasing body of evidence suggesting that
estrogens are a successful adjunct treatment for a variety of
neuropsychiatric disorders, including schizophrenia, depression,
and anxiety (Hughes et al., 2009; Torrey and Davis, 2012;
Kulkarni et al., 2014). A common hallmark of these disorders
is a loss of synaptic connectivity (Penzes et al., 2011). It has
been suggested that either targeting mechanisms that modulate
glutamatergic signaling or that restore lost connectivity may
be a viable therapeutic avenue in the treatment of various
neurological diseases including neuropsychiatric disorders (Gray
and Roth, 2007; Penzes et al., 2011; Paoletti et al., 2013). It is
tempting to hypothesize that some of the benefits seen after
estrogen administration may be due to regulation of dendritic
spine remodeling (Srivastava et al., 2013; Sellers et al., 2015).
However it is essential to determine themolecular underpinnings
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and the basis by which estrogens are beneficial in these disorders
to fully determine the potential for estrogen-based therapies.
As such, understanding the pathways and the receptors that
underlie the effects of estrogen on dendritic spine plasticity may
offer insights into novel therapeutic targets for treatments of
many neuropsychiatric disorders (Hughes et al., 2009; Srivastava
et al., 2013; Sellers et al., 2015).
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